Sagimet Biosciences to Participate in the Canaccord Genuity 46th Annual Growth Conference

Rhea-AI Summary

Sagimet Biosciences (Nasdaq: SGMT), a clinical-stage biopharmaceutical company focused on therapeutics targeting dysfunctional metabolic and fibrotic pathways, announced that its management will participate in the Canaccord Genuity 46th Annual Growth Conference on Tuesday, August 11, 2026, in Boston, MA, including a fireside chat at 1:00 p.m. ET.

Argus Aug 4 session 55 alerts

+11.75% close to close 1.6x rel. volume Open Argus

Details

News Market Reaction – SGMT

+7.2% Peak in 6 hr 16 min

$494.01M Market Cap

On Aug 4, the day this news came out, SGMT closed 11.75% above the previous close. Argus tracked a peak move of +7.2% during that session. Our momentum scanner recorded 55 alerts for this stock that day. Relative volume reached 1.6x the daily average during tracking.

Data tracked by StockTitan Argus for the Aug 4 session.

Market Context

On Aug 4, the day this news came out, the stock closed 11.8% above the previous close. The June 29 i...

Analysis

On Aug 4, the day this news came out, the stock closed 11.8% above the previous close. The June 29 index-addition announcement was followed by a 10.34% 24-hour move, offering a historical comparator for this conference notice. Recent insider records showed Net Selling, a separate risk context.

Key Figures

Conference edition: 46th annual Conference date: August 11, 2026 Fireside chat time: 1:00pm ET

Conference edition

46th annual

Canaccord Genuity Growth Conference

Conference date

August 11, 2026

Canaccord Genuity Growth Conference

Fireside chat time

1:00pm ET

August 11, 2026 conference participation

Historical Context

5 past events · Latest: Jun 29

5 events

1. Jun 29

   Index inclusion

   24h Move

   +10.3%

   Russell 2000 and Russell 3000 index inclusion became effective.

2. Jun 22

   Conference participation

   24h Move

   -0.6%

   Investor conference participation accompanied an inducement grant totaling 34,300 stock options.

3. May 27

   Clinical data

   24h Move

   +0.0%

   EASL posters described tolerability, biomarker engagement, and preclinical combination benefits.

4. May 13

   Conference participation

   24h Move

   -0.7%

   Management scheduled a fireside chat at the H.C. Wainwright conference.

5. May 12

   Earnings results

   24h Move

   -0.5%

   First-quarter results included financing, cash, expense, and net-loss updates.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

FOSTER CITY, Calif., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that management will participate in the Canaccord Genuity 46^th Annual Growth Conference on Tuesday, August 11, 2026, in Boston, MA with a fireside chat at 1:00pm ET (link here).

About Sagimet Biosciences

Sagimet is a clinical-stage biopharmaceutical company developing novel FASN inhibitors designed to target dysfunctional metabolic and fibrotic pathways in conditions resulting from the overproduction of the fatty acid, palmitate. FASN is a regulator of lipid synthesis, and a key pathway implicated in multiple diseases, such as acne, MASH and certain FASN-dependent tumor types. For additional information about Sagimet, please visit www.sagimet.com.

Investor Contact:
Joyce Allaire 
LifeSci Advisors 
JAllaire@LifeSciAdvisors.com

Media Contact:
Maggie Whitney
LifeSci Communications
mwhitney@lifescicomms.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Sagimet Biosciences (SGMT) present at the Canaccord Genuity 46th Annual Growth Conference?

Sagimet Biosciences will participate on Tuesday, August 11, 2026, at the Canaccord Genuity 46th Annual Growth Conference. According to Sagimet Biosciences, the company’s management will join a fireside chat scheduled for 1:00 p.m. Eastern Time in Boston, Massachusetts.

What is Sagimet Biosciences (SGMT) doing at the Canaccord Genuity 2026 Growth Conference?

Sagimet Biosciences management will participate in the Canaccord Genuity 46th Annual Growth Conference with a scheduled fireside chat. According to Sagimet Biosciences, the event will take place in Boston, Massachusetts, giving management a platform to discuss the company on August 11, 2026.

Where is Sagimet Biosciences’ fireside chat at the Canaccord Genuity 46th Annual Growth Conference being held?

Sagimet Biosciences’ fireside chat will be held in Boston, MA as part of the Canaccord Genuity 46th Annual Growth Conference. According to Sagimet Biosciences, the session is scheduled for 1:00 p.m. ET on August 11, 2026.

What time is Sagimet Biosciences’ (SGMT) fireside chat at the Canaccord Genuity conference on August 11, 2026?

Sagimet Biosciences’ fireside chat is scheduled for 1:00 p.m. Eastern Time on August 11, 2026. According to Sagimet Biosciences, this session is part of the Canaccord Genuity 46th Annual Growth Conference in Boston, Massachusetts.

What type of company is Sagimet Biosciences (Nasdaq: SGMT), which is attending the Canaccord Genuity 46th Annual Growth Conference?

Sagimet Biosciences is a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways. According to Sagimet Biosciences, this focus underpins its participation in investor conferences such as the Canaccord Genuity 46th Annual Growth Conference.